Part one of this four part video series from J&J introduces long-acting injectable (LAI) antipsychotics as an alternative to daily oral medications for people with schizophrenia. LAIs provide medication over weeks or months, which may help with adherence and reduce relapse risk. The event features research updates, perspectives from mental health professionals, and personal experiences to explore how LAIs may fit into treatment plans.
To learn more, watch the video here.
Contributor: Johnson & Johnson – Dr. Christoph Correll, Dr. Leslie Citrome, Dr. Rebecca Roma
